← Oncology Approval Tracker

FDA DECISION ·

Midostaurin capsules (first generic)

midostaurin · Teva Pharmaceuticals Development

First generic approvalFirst genericAcute myeloid leukemia and advanced mastocytosis
Open LinkedIn brief ↓

1 min read · estimated

Sources

APPROVED USE

What FDA approved

First generic of the referenced midostaurin capsules for adults with newly diagnosed FLT3-positive AML in the designated chemotherapy regimen, or with aggressive systemic mastocytosis, systemic mastocytosis with an associated hematologic neoplasm, or mast cell leukemia.

LAMPGEN ANALYSIS

Why it matters

This decision offers a generic option for established, distinct leukemia and mast-cell indications.

What research teams should watch

Confirm FLT3 status and chemotherapy phase in AML; keep disease-specific schedules and interaction checks separate.

PRIMARY RECORDS

Sources